[go: up one dir, main page]

IN2012DN05097A - - Google Patents

Download PDF

Info

Publication number
IN2012DN05097A
IN2012DN05097A IN5097DEN2012A IN2012DN05097A IN 2012DN05097 A IN2012DN05097 A IN 2012DN05097A IN 5097DEN2012 A IN5097DEN2012 A IN 5097DEN2012A IN 2012DN05097 A IN2012DN05097 A IN 2012DN05097A
Authority
IN
India
Application number
Inventor
Hubertus Hochrein
Original Assignee
Bavarian Nordic As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42321045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN05097(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bavarian Nordic As filed Critical Bavarian Nordic As
Publication of IN2012DN05097A publication Critical patent/IN2012DN05097A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/117Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/15Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/17Immunomodulatory nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN5097DEN2012 2009-12-18 2012-06-08 IN2012DN05097A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28777709P 2009-12-18 2009-12-18
EP10005348 2010-05-21
PCT/EP2010/007751 WO2011072871A1 (en) 2009-12-18 2010-12-17 Production of ifn-lambda by conventional dendritic cells and uses thereof

Publications (1)

Publication Number Publication Date
IN2012DN05097A true IN2012DN05097A (en) 2015-10-09

Family

ID=42321045

Family Applications (1)

Application Number Title Priority Date Filing Date
IN5097DEN2012 IN2012DN05097A (en) 2009-12-18 2012-06-08

Country Status (10)

Country Link
US (1) US9090897B2 (en)
EP (1) EP2513311B9 (en)
JP (2) JP2013514062A (en)
AU (1) AU2010333322B2 (en)
CA (1) CA2783510C (en)
DK (1) DK2513311T4 (en)
ES (1) ES2626595T5 (en)
IN (1) IN2012DN05097A (en)
NZ (1) NZ599677A (en)
WO (1) WO2011072871A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013047869A1 (en) * 2011-09-29 2013-04-04 興和株式会社 Pharmaceutical composition containing loxoprofen or salt thereof
US9556439B2 (en) * 2012-02-09 2017-01-31 Bavarian Nordic A/S Agonists and antagonists of toll-like receptor (TLR) 13
WO2017175774A1 (en) * 2016-04-04 2017-10-12 キッコーマン株式会社 COMPOSITION FOR PROMOTING INTERFERON λ PRODUCTION AND METHOD FOR PRODUCING SAME
CN107306939B (en) * 2017-07-31 2020-09-15 山东水发生命科学研究有限公司 Cell cryopreservation liquid for dendritic cells
EP3892739A1 (en) * 2020-04-09 2021-10-13 Centre Léon Bérard Type iii interferon for use as a biomarker to predict response to a cancer treatment
CN114917242A (en) * 2022-05-31 2022-08-19 复旦大学附属中山医院 Application of synthetic double-stranded RNA analogue in preventing respiratory tract transmitted virus through nose dropping and application thereof
WO2024017998A1 (en) * 2022-07-21 2024-01-25 Technische Universität Dresden M-csf for use in the prophylaxis and/or treatment of viral infections in states of immunosuppression
EP4309666A1 (en) * 2022-07-21 2024-01-24 Technische Universität Dresden M-csf for use in the prophylaxis and/or treatment of viral infections in states of immunosuppression

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3974167B2 (en) * 1992-03-31 2007-09-12 アーチ デベロプメント コーポレイション Methods and compositions for treating genes, tumors and viral infections, and preventing programmed cell death (apoptosis)
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
WO2002004002A2 (en) * 2000-07-11 2002-01-17 Bayer Aktiengesellschaft Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
EP2572714A1 (en) 2002-12-30 2013-03-27 3M Innovative Properties Company Immunostimulatory Combinations
CN101018567B (en) * 2004-07-20 2011-07-27 先灵公司 Induction of apoptosis in Toll-like receptor expressing tumor cells
CA2587676A1 (en) * 2004-11-19 2006-05-26 Institut Gustave Roussy Improved treatment of cancer by double-stranded rna
CN101652062A (en) * 2007-03-05 2010-02-17 犹他州立大学 Restrictive agonist of toll-like receptor 3 (tlr3)
JP5721428B2 (en) 2007-04-27 2015-05-20 バヴァリアン・ノルディック・アクティーゼルスカブ Induction of dendritic cell development by macrophage-colony stimulating factor (M-CSF)
US8053234B2 (en) * 2007-04-27 2011-11-08 Bavarian Nordic A/S Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
WO2009088401A2 (en) 2007-09-24 2009-07-16 Government Of The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Immunostimulatory combinations of tlr ligands and methods of use
US20100310600A1 (en) * 2008-02-15 2010-12-09 Carter William A Selective agonist of toll-like receptor 3

Also Published As

Publication number Publication date
DK2513311T3 (en) 2017-07-24
NZ599677A (en) 2014-10-31
DK2513311T4 (en) 2021-06-14
WO2011072871A1 (en) 2011-06-23
JP2016121157A (en) 2016-07-07
AU2010333322A1 (en) 2012-05-24
EP2513311B9 (en) 2021-08-18
JP2013514062A (en) 2013-04-25
ES2626595T3 (en) 2017-07-25
US9090897B2 (en) 2015-07-28
JP6263559B2 (en) 2018-01-17
EP2513311B1 (en) 2017-04-12
EP2513311A1 (en) 2012-10-24
ES2626595T5 (en) 2021-11-24
CA2783510C (en) 2019-01-08
CA2783510A1 (en) 2011-06-23
AU2010333322B2 (en) 2016-02-04
EP2513311B2 (en) 2021-03-24
US20120258082A1 (en) 2012-10-11

Similar Documents

Publication Publication Date Title
BE2015C040I2 (en)
BR112012008195A2 (en)
BR112012003062A2 (en)
BR112012008267A2 (en)
BR112012012396A2 (en)
BR112012000607A2 (en)
BR112012000665A2 (en)
BR112012003080A2 (en)
BR112012012487A2 (en)
BR112012003853A2 (en)
BR112012009797A2 (en)
BR112012012080A2 (en)
BR112012009446A2 (en)
BR112012009703A2 (en)
BR112012010357A2 (en)
BR112012007656A2 (en)
BR112012001263A2 (en)
BR112012000159A2 (en)
BR112012014856A2 (en)
BR112012002627A2 (en)
BR112012007654A2 (en)
BR112012007672A2 (en)
BR112012000255A2 (en)
BR112012000156A2 (en)
BR112012009404A2 (en)